Valvular & structural heart disease

Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis

J Am Coll CardiolPublished Proteomic cohort study with replication and Mendelian randomisation

Authors' conclusion

These findings identify MMP12 as a potential novel circulating biomarker of AS risk and C1QTNF1 as a new putative target to prevent AS progression.

Study context

Population
ARIC study participants in mid-life (V3) and late-life (V5); replication in Cardiovascular Health StudyV3
Participants
11,430 participants
Outcome
Proteins associated with AVmax and dimensionless index by echocardiography (V5) and with incident AV-related hospitalization (after V3)
Methodological detailsSomaScan aptamer-affinity assay (4,877 plasma proteins), cross-sectional and prospective analyses, independent replication sample, Mendelian randomization, AV tissue gene expression
  • SomaScan aptamer-affinity assay (4,877 plasma proteins)
  • Cross-sectional and prospective analyses
  • Independent replication sample
  • Mendelian randomization
  • AV tissue gene expression

Main finding

As reported in the abstract

Proteins associated with AVmax, dimensionless index and incident AV-related hospitalization
Proteins cross-sectionally associated with AVmax and dimensionless index at V5 and with risk of incident AV-related hospitalization after V3
52

Observational data: associations, not effects.

Further findings

Moderate or severe aortic stenosis (AS) (replication, Cardiovascular Health Study, n = 3,413)

Proteins significantly associated with adjudicated moderate or severe AS, incl. MMP12, C1QTNF1 and growth differentiation factor-15
6

MMP12: AVmax progression, AV calcification, AV tissue expression · 6 years

MMP12 associated with greater increase in AVmax over 6 years, greater AV calcification, and greater expression in calcific vs normal or fibrotic AV tissue

Mendelian randomization: AS and AVmax

C1QTNF1 had consistent potential causal effects on both AS and AVmax

Original publication

Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. Published 6 February 2024. doi:10.1016/j.jacc.2023.11.021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.